We explored the effects of TPST2 knock-down on tumor growth and the host immune system in a syngeneic mouse model using MC38 cells (mouse colon cancer cells), which were reportedly sensitive to anti-PD1 treatment [29]. The gene discussed is TPST2; the disease is colonic neoplasm.